Graphen

Graphen is a private AI company headquartered in New York that develops graph-based artificial intelligence platforms across multiple industries, including healthcare and drug discovery. Its healthcare activities are organized through Graphen Health, which focuses on AI-enabled genomic analysis and personalized treatment support, and Graphen Drugomics, which applies AI to drug discovery for rare and common diseases. The company describes Atom as its medical AI and drug design platform, supporting target identification, multi-omics analytics, protein analysis, ADME prediction, antibody developability, drug generation, and precision medicine workflows. Public materials indicate Graphen is transitioning from a technical AI service company into a more therapeutics-oriented business, with early pipeline work in disease areas such as muscular dystrophy and glioblastoma and an announced focus on protein kinase targets. Based on disclosed information, it appears to be an AI-enabled biotech/healthtech platform company rather than a company with a mature disclosed clinical pipeline or marketed therapeutics.